Corbus Pharmaceuticals Holdings (CRBP) Interest Coverage Ratio (2013 - 2024)

Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Interest Coverage Ratio of 4.99 in Q3 2024, up 103.54% quarter-over-quarter from 2.45 in Q2 2024, and up 151.59% on a YoY basis from 1.99 in Q4 2023.

Corbus Pharmaceuticals Holdings (CRBP) Interest Coverage Ratio (2013 - 2024) Analysis & Trends

Corbus Pharmaceuticals Holdings' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 4.99 for Q3 2024.

  • In Q3 2024, Interest Coverage Ratio rose 151.59% year-over-year to 4.99; the TTM figure through Jun 2025 stood at 92.5 (down 1754.55% YoY), while the FY2024 annual figure was 3.37, up 128.85% from the prior year.
  • Interest Coverage Ratio was 4.99 for Q3 2024 at Corbus Pharmaceuticals Holdings, up from 2.45 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 4.99 in Q3 2024 to a low of 10.86 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 3.58
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -258.33
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 11.50
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 547.67
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - 11.79
10 Corbus Pharmaceuticals Holdings 133.67 Mn 105.86 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 4.99
Jun 30, 2024 2.45
Mar 31, 2024 1.23
Dec 31, 2023 -10.86
Sep 30, 2023 -9.68
Jun 30, 2023 -8.19
Mar 31, 2016 -449.02
Dec 31, 2015 -2,341.55
Jun 30, 2015 -6,520.85
Mar 31, 2015 -1,568.23
Dec 31, 2014 -1,289.99
Sep 30, 2014 -1,258.77
Jun 30, 2014 -41.34
Mar 31, 2014 -9.46
Dec 31, 2013 -19.99
Sep 30, 2013 -4.84